Dec 05, 2022 / 01:30PM GMT
Operator
Good morning, and welcome to the Protalix BioTherapeutics KOL webinar. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Protalix website following the conclusion of the event.
Before we begin, please note that this presentation, including all verbal remarks contain forward-looking statements. The accuracy of which depends on future events outside the company's control, and therefore, might cause actual results to differ materially from those forward-looking statements. In the case of any questions or discrepancies, we defer to the company's public documents available from its website and filed with the SEC.
I'd now like to turn the call over to Dror Bashan, President and Chief Executive Officer at Protalix Biotherapeutics. Please go ahead, Dror.
Dror Bashan - Protalix BioTherapeutics, Inc. - President, CEO & Director
Thank you, Tara, and good morning and good afternoon to everybody who took the time to join the call. We are now -- actually organized this session, this KOL event
Protalix Biotherapeutics Inc Corporate Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers